Join our daily newsletter At The Bell to receive exclusive market insights
- Advanced Human Imaging (AHI) has announced the advancement of its Meta-Twin offering, a real-time, on-screen digital health assessment
- The company says the demand for digital diagnosis spiked during the pandemic and has since been a motivator for its technology
- AHI also announced it will launch derma scanning at the 2022 Consumer Electronics Show (CES) hosted in the US
- AHI’s partner-facing platform CompleteScan will serve as a portal for its partners’ users to access the product
- Advanced Human Imaging shares ended the day down 2.78 per cent and traded at 88 cents a share
Advanced Human Imaging (AHI) has announced the advancement of its Meta-Twin offering, a real-time, on-screen digital health assessment.
AHI has advanced the company’s on-device technology suite with the data convergence of risk assessment via the combining of body dimensions, body composition, and vital signs, in response to the reportedly urgent need for digital assessment and diagnostics as a result of the COVID-19 pandemic and the need for remote care.
AHI’s partner-facing platform CompleteScan will serve as a portal for its partners’ users to access the product. These combined captures are reportedly positioned to uncover chronic disease risk signs that would ordinarily necessitate a face-to-face examination with a care professional.
The AHI Meta-Twin creates a virtual world in which digital avatars connect an individual’s health data via the CompleteScan 2D-3D avatar in an augmented reality environment utilising a screen or VR headsets.
“We are now advancing the 2D-3D capture capabilities into our Meta-Twin, with the intention to allow individuals to interact in real-time with their avatar identifying and understanding their assessment of risk at their fingertips in a virtual and augmented reality environment,” CEO Vlado Bosanac said.
In addition, during CES Las Vegas in January 2022, AHI will exhibit its derma scanning AI in CompleteScan with over 500 skin conditions over 133 categories.
“These new advancements in AHI’s capabilities have formed part of our long-term strategy over the past 2 years,” Mr Bosanac said.
“We accelerated the rollout due to the increase we have seen in the Telemedicine and Telehealth industry due to the COVID-19 pandemic.
“AHI… is becoming a device-based health triage provider by allowing insurers, medical professionals, and healthcare providers to use an advanced tool, that demonstrates an individual’s risk markers with speed and convenience.”
AHI announced in September 2020 that it had developed the world’s first artificial intelligence and machine learning models capable of mimicking an individual’s medical images pertaining to body composition (including body fat percentage) via mobile device image capture.
While the company notes it is not a 100 per cent replacement of an actual medical scan, the results are “highly correlated”, with AHI claiming preliminary analysis shows its models predicted tissue and body fat images that had an average correlation of up to 97 per cent, compared to Dual Energy X-ray Absorptiometry.
Advanced Human Imaging shares ended the day down 2.78 per cent and traded at 88 cents a share.
